Question 1

Which countries lead Infectious Aortic and Vascular Conditions research?

Accepted Answer

By volume, the United States and China publish the most (798 and 351 works in 2022-now).

Question 2

Which institutions lead Infectious Aortic and Vascular Conditions research?

Accepted Answer

By volume in 2022-now, Mayo Clinic publishes the most Infectious Aortic and Vascular Conditions research, followed by Harvard University and Cleveland Clinic.

Question 3

Who are the leading researchers in Infectious Aortic and Vascular Conditions?

Accepted Answer

The most-cited researchers publishing on Infectious Aortic and Vascular Conditions include Douglas G. Altman, Stephan Windecker and Gregory Y.H. Lip.

Question 4

Where is Infectious Aortic and Vascular Conditions research done?

Accepted Answer

The largest centres of Infectious Aortic and Vascular Conditions research in 2022-now are Beijing (China), Tokyo (Japan), New York (United States) and Shanghai (China). Among places with at least 20 works in it, it is an unusually large share of all research in Cleveland.

Question 5

Where is the best place to study Infectious Aortic and Vascular Conditions?

Accepted Answer

Among universities, judged by research, Harvard University, Sichuan University and University of Bern score highest, combining citation excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

Question 6

Is Infectious Aortic and Vascular Conditions research growing?

Accepted Answer

Output in 2022-2025 was 8% higher than in 2018-2021, peaking in 2025. The fastest-growing topics are Infectious Aortic and Vascular Conditions.

Question 7

What are the most cited papers in Infectious Aortic and Vascular Conditions?

Accepted Answer

The most cited paper in Infectious Aortic and Vascular Conditions is "Treatment of Infections Associated with Surgical Implants" (Rabih O. Darouiche, 2004), with 2,275 citations. Next come "Transluminal Placement of Endovascular Stent-Grafts for the Treatment of Descending Thoracic Aortic Aneurysms" (1,711) and "Aneurysm Syndromes Caused by Mutations in the TGF-β Receptor" (1,663).